Arcus Biosciences Inc (RCUS)
17.16
+0.72
(+4.38%)
USD |
NYSE |
Dec 04, 13:47
Arcus Biosciences Market Cap: 1.570B for Dec. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| December 03, 2024 | 1.504B |
| December 02, 2024 | 1.459B |
| November 29, 2024 | 1.413B |
| November 27, 2024 | 1.446B |
| November 26, 2024 | 1.445B |
| November 25, 2024 | 1.332B |
| November 22, 2024 | 1.345B |
| November 21, 2024 | 1.307B |
| November 20, 2024 | 1.338B |
| November 19, 2024 | 1.328B |
| November 18, 2024 | 1.321B |
| November 15, 2024 | 1.437B |
| November 14, 2024 | 1.443B |
| November 13, 2024 | 1.504B |
| November 12, 2024 | 1.535B |
| November 11, 2024 | 1.624B |
| November 08, 2024 | 1.633B |
| November 07, 2024 | 1.506B |
| November 06, 2024 | 1.439B |
| November 05, 2024 | 1.399B |
| November 04, 2024 | 1.424B |
| November 01, 2024 | 1.418B |
| October 31, 2024 | 1.400B |
| October 30, 2024 | 1.464B |
| October 29, 2024 | 1.502B |
| Date | Value |
|---|---|
| October 28, 2024 | 1.524B |
| October 25, 2024 | 1.493B |
| October 24, 2024 | 1.631B |
| October 23, 2024 | 1.586B |
| October 22, 2024 | 1.537B |
| October 21, 2024 | 1.553B |
| October 18, 2024 | 1.687B |
| October 17, 2024 | 1.669B |
| October 16, 2024 | 1.634B |
| October 15, 2024 | 1.627B |
| October 14, 2024 | 1.655B |
| October 11, 2024 | 1.681B |
| October 10, 2024 | 1.565B |
| October 09, 2024 | 1.623B |
| October 08, 2024 | 1.599B |
| October 07, 2024 | 1.583B |
| October 04, 2024 | 1.523B |
| October 03, 2024 | 1.401B |
| October 02, 2024 | 1.408B |
| October 01, 2024 | 1.411B |
| September 30, 2024 | 1.399B |
| September 27, 2024 | 1.409B |
| September 26, 2024 | 1.407B |
| September 25, 2024 | 1.396B |
| September 24, 2024 | 1.426B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
357.24M
Minimum
Dec 05 2019
3.405B
Maximum
Nov 23 2021
1.667B
Average
1.544B
Median
Sep 13 2023
Market Cap Benchmarks
| Merck & Co Inc | 256.83B |
| Regeneron Pharmaceuticals Inc | 82.37B |
| NovaBay Pharmaceuticals Inc | 2.931M |
| Palatin Technologies Inc | 19.16M |
| iBio Inc | 24.15M |
Market Cap Related Metrics
| PS Ratio | 5.610 |
| Price to Book Value | 2.779 |
| Price | 17.16 |
| Earnings Yield | -18.36% |